References
- 1. Chommel BB. Cat-scratch disease. Rev Sci Tech 2000; 19(1): 136–50.10.20506/rst.19.1.1204
- 2. Windsor JJ. Cat-scratch disease: epidemiology, aetiology and treatment. Br J Biomed Sci 2001; 58: 101.
- 3. Debré R, Lamy M, Jammet ML, et al. La maladie des griffes de chat. Bull, Membres Soc méd Hôp Paris 1950; 66: 76–79.
- 4. Wear DJ, Margileth AM, Hadfield T.L, et al. Cat scratch disease: a bacterial infection. Science 1983; 221: 1403–1405.10.1126/science.6612349
- 5. Regnery RL, Olson JG, Bradley AP, et al. Serological response to “Rochalimaea henselae” antigen in suspected cat-scratch disease. Lancet 1992; 339: 1443–1445.10.1016/0140-6736(92)92032-B
- 6. Bass JW, Vincent JM, Person DA. The expanding spectrum of bartonella infections: II cat-scratch disease. Pediatr Infect Dis J 1997; 16: 163–179.10.1097/00006454-199702000-000029041596
- 7. Andrew M, Margileth MD. Recent Advances in Diagnosis and Treatment of Cat Scratch Disease. Current Infectious Disease Reports 2000; 2: 141–146.10.1007/s11908-000-0026-811095849
- 8. Carithers HA, Carithers CM, Edwards RO. Cat-scratch disease: its natural history. JAMA 1969; 207: 312–316.10.1001/jama.1969.03150150024005
- 9. Biancardi AL, Curi AL. Cat-Scratch Disease. Ocul Immunol Inflamm 2014; 22(2): 148–154.10.3109/09273948.2013.83363124107122
- 10. Wong MT, Dolan MJ, Lattuada CP et al. Neuroretinitis, aseptic meningitis, and lymphadenitis associated with Bartonella (Rochalimaea) henselae infection in immunocompetent patients and patients infected with human immunodeficiency virus type 1. Clin Infect Dis 1995; 21(2): 352–60.10.1093/clinids/21.2.3528562744
- 11. Nelson CA, Saha S, Mead PS. Cat-Scratch Disease in the United States, 2005-2013. Emerg Infect Dis 2016; 22(10): 1741–1746.10.3201/eid2210.160115503842727648778
- 12. Pons I, Sanfeliu I, Cardenosa N, et al. Serological evidence of Bartonella henselae infection in healthy people in Catalonia, Spain. Epidemiol Infect 2008; 136: 1712–1716.10.1017/S0950268808000368287077818294428
- 13. McGill S, Wesslen L, Hjelm E, et al. Bartonella spp. seroprevalence in healthy Swedish blood donors. Scand J Infect Dis 2005; 37: 723–730.10.1080/0036554051001215216191889
- 14. Liu Q, Eremeeva ME, Li D. Bartonella and Bartonella infections in China: from the clinic to the laboratory. Comp Immunol Microbiol Infect Dis 2012; 35: 93–102.10.1016/j.cimid.2012.01.00222304899
- 15. Kwon HY, Im JH, Lee SM, et al. The seroprevalence of Bartonella henselae in healthy adults in Korea. Korean J Intern Med 2017; 32: 530–535.10.3904/kjim.2016.010543280028490714
- 16. Mandell GL, Douglas RG, Bennett JE, et al. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. Philadelphia Elsevier 2015; 8(2): 3566–3585.
- 17. Tsuneoka H, Tsukahara M. Analysis of data in 30 patients with cat scratch disease without lymph-adenopathy. J Infect Chemother 2006; 12: 224–226.10.1007/s10156-006-0454-Y16944264
- 18. Zenone T. Systemic Bartonella henselae Infection in Immunocompetent Adult Presenting as Fever of Unknown Origin. Case Rep Med 2011; 2011:183937.10.1155/2011/183937309919421629850
- 19. Tolia J, Smith LG. Fever of Unknown Origin: Historical and Physical Clues to Making the Diagnosis. Infect Dis Clin N Am 2007; 21: 917–936.10.1016/j.idc.2007.08.01118061082
- 20. Margileth AM. Dermatologic manifestations and update of cat scratch. Pediatr Dermatol 1988; 5(1): 1–9.10.1111/j.1525-1470.1988.tb00876.x3380756
- 21. Carithers HA. Cat-scratch disease. An overview based on a study of 1,200 patients. Am J Dis Child 1985; 139(11): 1124–1133.10.1001/archpedi.1985.021401300620314061408
- 22. Kasraeian S, Allison CD, Ahlmann ER, et al. A Comparison of Fine-needle Aspiration, Core Biopsy, and Surgical Biopsy in the Diagnosis of Extremity Soft Tissue Masses. Clin Orthop Relat Res 2010; 468: 2992–3002.10.1007/s11999-010-1401-x294768620512437
- 23. Margileth AM. Cat-scratch disease update. Am J Dis Child 1984; 138: 711–713.10.1001/archpedi.1984.021404600030036204524
- 24. Margileth AM. Recent advances in diagnosis and treatment of cat scratch disease. Curr Infect Dis Rep 2000; 2: 141–146.10.1007/s11908-000-0026-811095849
- 25. Herremans M, Vermeulen MJ, Van de Kassteele J, et al. The use of Bartonella henselae-specific age dependent IgG and IgM in diagnostic models to discriminate diseased from non-diseased in Cat Scratch Disease serology. J Microbiol Methods 2007; 71: 107–113.10.1016/j.mimet.2007.09.00417916395
- 26. Sander A, Posselt M, Oberle K, et al. Seroprevalence of antibodies to Bartonella henselae in patients with cat scratch disease and in healthy controls: evaluation and comparison of two commercial serological tests. Clin Diagn Lab Immunol 1998; 5: 486–490.10.1128/CDLI.5.4.486-490.1998956049665953
- 27. Bergmans AMC, Peeters MF, Schellenkens JFP, et al. Pitfalls and fallacies of cat scratch disease serology: evaluation of Bartonella henselae-based indirect fluorescence assay and enzyme-linked immunoassay. J Clin Microbiol 1997, 35: 1931–1937.10.1128/jcm.35.8.1931-1937.19972298799230358
- 28. Arisoy ES, Correa AG, Wagner ML, et al. Hepatosplenic cat-scratch disease in children: selected clinical features and treatment. Clin Infect Dis 1999; 28: 778–784.10.1086/51519710825038
- 29. Margileth AM. Antibiotic therapy for cat-scratch disease: clinical study of therapeutic outcome in 268 patients and a review of the literature. Pediatr Infect Dis J 1992; 11(6): 474–478.10.1097/00006454-199206000-00010
- 30. Bass JW, Freitas BC, Freitas AD, et al. Prospective randomized double blind placebo-controlled evaluation of azithromycin for treatment of cat-scratch disease. Pediatr Infect Dis J 1998; 17: 447–52.10.1097/00006454-199806000-000029655532